Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsMoneycontol

    Moneycontol

    Jump to
    • Specialty portfolio emerges as a strong growth driver over the years

      Specialty portfolio emerges as a strong growth driver over the years

      Sun Pharma is the largest pharma company of India with about 8.2 percent market share in the domestic formulation industry. It also gets a sizeable revenue from its global specialty business which fetches higher margin than the pharma generic business. Key watch for company in coming months is the progress for Specialty pipeline, the US tariffs on pharma products and expansion of domestic field force. 

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347